the study was aimed at comparing effectiveness , safety and possible steroid sparing effects of indoprofen ( 800 mg/day ) and indomethacin ( 100 mg/day ) , in patients with classical or definite rheumatoid arthritis , in active phase , receiving basic steroid treatment at a fixed , not reducible dosage .
C0021246
indomethacin
C0003873
rheumatoid arthritis